JBIO
Jade Biosciences
JBIO
JBIO
78 hedge funds and large institutions have $273M invested in Jade Biosciences in 2025 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 22 increasing their positions, 23 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
13% less capital invested
Capital invested by funds: $315M → $273M (-$42.2M)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $915K
3,705.01% less ownership
Funds ownership: 3,801.92% → 96.91% (-3,705%)
Holders
78
Holding in Top 10
1
Calls
–
Puts
$915K
Top Buyers
| 1 | +$3.76M | |
| 2 | +$1.56M | |
| 3 | +$1.4M | |
| 4 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$1.16M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$928K |
Top Sellers
| 1 | -$3.1M | |
| 2 | -$1.98M | |
| 3 | -$1.98M | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
-$1.06M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$698K |
